Preliminary data of the risk stratification score (RISE) prospective, multi-centre, 3-year, validation trial in idiopathic pulmonary fibrosis.
G. Manzetti (Rome, Italy), K. Hosein (London, Canada), M. Cecchini (London, Canada), K. Kwan (London, Canada), M. Abdelrazek (London, Canada), M. Zompatori (Milan, Italy), P. Rogliani (Rome, Italy), M. Mura (London, Canada)
Source: International Congress 2022 – New tools for the diagnosis of interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Manzetti (Rome, Italy), K. Hosein (London, Canada), M. Cecchini (London, Canada), K. Kwan (London, Canada), M. Abdelrazek (London, Canada), M. Zompatori (Milan, Italy), P. Rogliani (Rome, Italy), M. Mura (London, Canada). Preliminary data of the risk stratification score (RISE) prospective, multi-centre, 3-year, validation trial in idiopathic pulmonary fibrosis.. 3424
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|